The life sciences tools and diagnostics industries have entered a period of profound maturity.
While technological progress is accelerating, founders and executives face tighter public budgets, evolving investor mindsets, and a shifting macroeconomic climate.
In this episode of DxPx Dialogues , host Wolfgang F.
Kaminski sits down with Peer Schatz , a legendary entrepreneur, co-founder, and investor who has spent decades shaping the global life sciences landscape.
Because developing a diagnostic assay or a complex lab tool requires years of large capital investment, life science development cycles operate on much longer timelines than digital software.
To mitigate this inherent risk, Schatz focuses deeply on character, emotional agility, and inspiration over mere sales pitches.
4.
The New Wave of Consolidation: Private Equity Stepping In The conversation also turned to massive industry movements, highlighting strategic mega-transactions like Waters Corporation’s $17.
